Literature DB >> 3177305

Outcome of neonatal strokes.

S K Sran1, R J Baumann.   

Abstract

We examined the clinical outcome of 17 children, 1 to 11 years of age, who experienced major cerebral artery infarctions (strokes) as neonates. Nine of the 17 children had left middle cerebral artery (MCA) infarctions, five had right MCA infarctions, two had bilateral MCA infarctions, and one had a left posterior cerebral artery infarction. Fourteen of the 17 children developed seizures as neonates. Most of these children who developed seizures were neurologically abnormal as neonates, became seizure free and neurologically normal early in the first year of life, and their anticonvulsant therapies were discontinued. After a seizure-free period of one to eight years, three of the 14 patients again required anticonvulsant therapy for seizure control. Two of the 16 surviving children continue to be severely handicapped while 11 of the 16 are making apparently normal developmental progress. One of the two children presently attending school has cognitive deficits appropriate to the site affected by the original infarction. Most children with neonatally diagnosed strokes appear to have a good short-term outcome, but later onset of seizures and subsequent recognition of cognitive deficits may not be uncommon.

Entities:  

Mesh:

Year:  1988        PMID: 3177305     DOI: 10.1001/archpedi.1988.02150100080031

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  11 in total

1.  Unilateral neonatal cerebral infarction in full term infants.

Authors:  J Estan; P Hope
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-03       Impact factor: 5.747

2.  Perinatal cortical infarction within middle cerebral artery trunks.

Authors:  P Govaert; E Matthys; A Zecic; F Roelens; A Oostra; B Vanzieleghem
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-01       Impact factor: 5.747

3.  Intranasal pyrrolidine dithiocarbamate decreases brain inflammatory mediators and provides neuroprotection after brain hypoxia-ischemia in neonatal rats.

Authors:  Zhi Wang; Huijuan Zhao; Shuling Peng; Zhiyi Zuo
Journal:  Exp Neurol       Date:  2013-08-29       Impact factor: 5.330

4.  Reduced PLP2 expression increases ER-stress-induced neuronal apoptosis and risk for adverse neurological outcomes after hypoxia ischemia injury.

Authors:  Lilei Zhang; Tao Wang; David Valle
Journal:  Hum Mol Genet       Date:  2015-10-28       Impact factor: 6.150

5.  Intranasal basic fibroblast growth factor attenuates endoplasmic reticulum stress and brain injury in neonatal hypoxic-ischaemic injury.

Authors:  Zhenlang Lin; Yingying Hu; Zhouguang Wang; Shulin Pan; Hao Zhang; Libing Ye; Hongyu Zhang; Mingchu Fang; Huai Jiang; Junming Ye; Jian Xiao; Li Liu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

6.  Major brain lesions detected on sonographic screening of apparently normal term neonates.

Authors:  L W Wang; C C Huang; T F Yeh
Journal:  Neuroradiology       Date:  2004-04-22       Impact factor: 2.804

7.  Perinatal stroke and the risk of developing childhood epilepsy.

Authors:  Meredith R Golomb; Bhuwan P Garg; Karen S Carvalho; Cynthia S Johnson; Linda S Williams
Journal:  J Pediatr       Date:  2007-08-23       Impact factor: 4.406

8.  Dexmedetomidine Postconditioning Reduces Brain Injury after Brain Hypoxia-Ischemia in Neonatal Rats.

Authors:  Xiaoyan Ren; Hong Ma; Zhiyi Zuo
Journal:  J Neuroimmune Pharmacol       Date:  2016-03-02       Impact factor: 4.147

9.  Isoflurane postconditioning induces concentration- and timing-dependent neuroprotection partly mediated by the GluR2 AMPA receptor in neonatal rats after brain hypoxia-ischemia.

Authors:  Ying Xu; Hang Xue; Ping Zhao; Yating Yang; Guoyu Ji; Weiwei Yu; Guang Han; Mengmeng Ding; Feifei Wang
Journal:  J Anesth       Date:  2016-01-25       Impact factor: 2.078

10.  Sevoflurane postconditioning provides neuroprotection against brain hypoxia-ischemia in neonatal rats.

Authors:  Xiaoyan Ren; Zhi Wang; Hong Ma; Zhiyi Zuo
Journal:  Neurol Sci       Date:  2014-04-05       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.